These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Management of celiac disease in daily clinical practice. Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262 [TBL] [Abstract][Full Text] [Related]
26. Celiac disease: from pathogenesis to novel therapies. Schuppan D; Junker Y; Barisani D Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641 [TBL] [Abstract][Full Text] [Related]
27. Celiac disease: how complicated can it get? Tjon JM; van Bergen J; Koning F Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732 [TBL] [Abstract][Full Text] [Related]
28. Structural basis of T cell receptor specificity and cross-reactivity of two HLA-DQ2.5-restricted gluten epitopes in celiac disease. Ciacchi L; Farenc C; Dahal-Koirala S; Petersen J; Sollid LM; Reid HH; Rossjohn J J Biol Chem; 2022 Mar; 298(3):101619. PubMed ID: 35065967 [TBL] [Abstract][Full Text] [Related]
29. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease. Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999 [TBL] [Abstract][Full Text] [Related]
30. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease. Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344 [TBL] [Abstract][Full Text] [Related]